CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company using the immune system to cure disease, today announced that Ari Gesher has joined as the first head of technology. He will oversee ...

Excluded items identified in the reconciliation schedule are tax effected by application of a non-GAAP effective tax rate. The non-GAAP tax provision is adjusted for items, the nature of which and/or ...

Climb Bio appointed Dr. Perrin Wilson as Chief Business Officer to strengthen its leadership in developing immune-mediated disease treatments. Climb Bio, Inc. has announced the appointment of Dr.

May 1(Reuters) - Bio-Techne (TECH.O), opens new tab on Wednesday beat third-quarter profit and revenue estimates, helped by better-than-expected demand for its cell and gene therapy products and ...

Aug 1 (Reuters) - Bio-Rad Laboratories (BIO.N), opens new tab cut its annual revenue growth forecast on Thursday, dragged down by weak demand for clinical diagnostics products from biotech clients.

Rejuvenate Bio, a biotechnology company developing gene therapies for age-related and chronic diseases, today announced the closing of a $6 million financing round led by VCapital, with participation ...

Huons Group is accelerating its focus on pharmaceuticals and bio-business through subsidiary restructuring and mergers and acquisitions (M&A). The company is overhauling its existing structure ...

Spear Bio, an innovator in ultrasensitive protein biomarker detection, today announced plans to unveil new SPEAR immunoassay and instrument innovations at the Alzheimer’s Association International ...

India's bio-energy growth drives enzyme demand across industries, highlighting Novonesis' role in transforming bio-solutions and market expansion.